The FDA approved the first-of-its-kind pediatric pulmonary valve device that grows with children to reduce the need for repeat open-heart surgeries. Typically, children who need a new pulmonary valve receive prosthetic aortic valves adapted for use in the pulmonary position,…
Nurse communication may be connected to five-star ratings in quality and patient experience at heart hospitals. Becker’s compared nurse and physician communication star ratings from CMS’ Hospital Consumer Assessment of Healthcare Providers and Systems survey released Aug. 13, which captures…
Healthgrades named 144 hospitals recipients of its 2027 Cardiology Excellence Award Oct. 27. The award recognizes hospitals that deliver superior clinical outcomes in heart bypass surgery, coronary interventional procedures, heart valve surgery, and the treatment of heart attack and heart…
Boston-based Tufts Medicine is using a three-layer approach to meet rising demand for mitral valve care while keeping quality care. Mitral valve disease rates rise steeply with age, and the number of Americans 65 and older is projected to grow…
New York City-based Montefiore Einstein’s remote monitoring program for patients with uncontrolled blood pressure has lowered patients’ systolic blood pressure by an average of 10 points within six months, a drop leaders estimate cuts their risk of heart attack and…
Stay current with Cardiology.
Becker’s Cardiology Newsletter is sent Tuesday and Thursday.
Mass General Brigham is working to eliminate internal competition among its hospitals, and the changes have improved patient access, volume and fellowship training. “Three years ago,I was chief of cardiology on our Mass General campus,” Patrick Ellinor, MD, PhD, executive…
AI-generated interpretations of echocardiograms had comparable accuracy to preliminary interpretations by sonographers, and cardiologists spent about half the time finalizing each scan, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2026. For the study, an AI…
Nearly 90% of cardiologists report prescribing GLP-1s to patients to reduce cardiovascular risk, a Nov. 6 Medscape report found. “Medscape Issues in Cardiology Report 2026: Balancing Medical Advances and Practice Demands” surveyed 152 cardiologists between March 3 and April 16.…
Two promising heart drugs did not perform better than placebo in large clinical trials — a blow to many cardiologists and companies who were betting on the drugs’ promise, The New York Times reported Nov. 7. Novartis’ pelacarsen and Novo…
The American College of Cardiology is “deeply disappointed” in CMS’ final 2027 Medicare Physician Fee Schedule, saying several finalized policies will make it harder for cardiovascular clinicians to care for patients. CMS released the final fee schedule Nov. 5, alongside…